Avacta Group plc: Avacta Announces AffiDx SARS-CoV-2 Antigen

Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer and pre|CISION platforms is pleased

Related Keywords

South Africa , United Kingdom , Madrid , Spain , Alastair Smith , Lily Jeffery , Avacta Group , Zyme Communications , World Health Organisation , Chief Executive , Regional Media , Avacta , Group , Nnounces , Ffidx , Cars , Ntigen , Bilateral , Low , Pest , Detects , Micron , Variant ,